Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Rogaine Extra Strength approved by FDA as OTC

Nov. 19, 1997

Cellegy to acquire nitroglycerin-based product for anorectal conditions

Nov. 6, 1997

KGF fragments from Chiron display wound-healing activity

Nov. 5, 1997

Lifecore reaches patient enrollment milestone in Intergel study

Oct. 30, 1997

Differin is equieffective but better tolerated than Retin A in patients with acne

Oct. 29, 1997

Apligraf comparable to autograft for donor site wounds

Oct. 29, 1997

VIMRxyn enters phase II for treatment of skin diseases

Oct. 27, 1997

Topical antiinflammatory activity of COX-2 inhibitors assessed

Oct. 27, 1997

ARS discloses new 5alpha-reductase inhibitors

Oct. 27, 1997

ADCON-L up for advisory committee review

Oct. 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...